Report Detail
COVID-19 Impact on Global Migraine Drugs, Market Insights and Forecast to 2026
- RnM4084645 |
- 30 June, 2020 |
- Global |
- 151 Pages |
- QYResearch |
- Pharma & Healthcare
Migraine Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Migraine Drugs market is segmented into
Sumatriptan
Zolmitriptan
Rizatriptan
Others Drug
Segment by Application, the Migraine Drugs market is segmented into
Hospitals
Clinics
Household Use
Others
Regional and Country-level Analysis
The Migraine Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Migraine Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Migraine Drugs Market Share Analysis
Migraine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Migraine Drugs business, the date to enter into the Migraine Drugs market, Migraine Drugs product introduction, recent developments, etc.
The major vendors covered:
Allergan
Merck
Pfizer
Teva
Pfizer
Johnson & Johnson
Endo International
GlaxoSmithKline
Impax
Abbott
Bayer
Eli Lilly
Ethypharm
Kowa Pharmaceuticals America
Winston Pharmaceuticals
AstraZeneca
1 Study Coverage
- 1.1 Migraine Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Migraine Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Migraine Drugs Market Size Growth Rate by Type
- 1.4.2 Sumatriptan
- 1.4.3 Zolmitriptan
- 1.4.4 Rizatriptan
- 1.4.5 Others Drug
- 1.5 Market by Application
- 1.5.1 Global Migraine Drugs Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Household Use
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Migraine Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Migraine Drugs Industry
- 1.6.1.1 Migraine Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Migraine Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Migraine Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Migraine Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Migraine Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Migraine Drugs Revenue 2015-2026
- 2.1.2 Global Migraine Drugs Sales 2015-2026
- 2.2 Migraine Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Migraine Drugs Competitor Landscape by Players
- 3.1 Migraine Drugs Sales by Manufacturers
- 3.1.1 Migraine Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Migraine Drugs Revenue by Manufacturers
- 3.2.1 Migraine Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Migraine Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Migraine Drugs Revenue in 2019
- 3.2.5 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Migraine Drugs Price by Manufacturers
- 3.4 Migraine Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Migraine Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Migraine Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Migraine Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Migraine Drugs Sales by Type (2015-2020)
- 4.1.2 Global Migraine Drugs Revenue by Type (2015-2020)
- 4.1.3 Migraine Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Migraine Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Migraine Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Migraine Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Migraine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Migraine Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Migraine Drugs Sales by Application (2015-2020)
- 5.1.2 Global Migraine Drugs Revenue by Application (2015-2020)
- 5.1.3 Migraine Drugs Price by Application (2015-2020)
- 5.2 Migraine Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Migraine Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Migraine Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Migraine Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Migraine Drugs by Country
- 6.1.1 North America Migraine Drugs Sales by Country
- 6.1.2 North America Migraine Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Migraine Drugs Market Facts & Figures by Type
- 6.3 North America Migraine Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Migraine Drugs by Country
- 7.1.1 Europe Migraine Drugs Sales by Country
- 7.1.2 Europe Migraine Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Migraine Drugs Market Facts & Figures by Type
- 7.3 Europe Migraine Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Migraine Drugs by Region
- 8.1.1 Asia Pacific Migraine Drugs Sales by Region
- 8.1.2 Asia Pacific Migraine Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Migraine Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Migraine Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Migraine Drugs by Country
- 9.1.1 Latin America Migraine Drugs Sales by Country
- 9.1.2 Latin America Migraine Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Migraine Drugs Market Facts & Figures by Type
- 9.3 Central & South America Migraine Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Migraine Drugs by Country
- 10.1.1 Middle East and Africa Migraine Drugs Sales by Country
- 10.1.2 Middle East and Africa Migraine Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Migraine Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Migraine Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Corporation Information
- 11.1.2 Allergan Description, Business Overview and Total Revenue
- 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Allergan Migraine Drugs Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Merck
- 11.2.1 Merck Corporation Information
- 11.2.2 Merck Description, Business Overview and Total Revenue
- 11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Migraine Drugs Products Offered
- 11.2.5 Merck Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description, Business Overview and Total Revenue
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Migraine Drugs Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Teva
- 11.4.1 Teva Corporation Information
- 11.4.2 Teva Description, Business Overview and Total Revenue
- 11.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Teva Migraine Drugs Products Offered
- 11.4.5 Teva Recent Development
- 11.5 Pfizer
- 11.5.1 Pfizer Corporation Information
- 11.5.2 Pfizer Description, Business Overview and Total Revenue
- 11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Migraine Drugs Products Offered
- 11.5.5 Pfizer Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Corporation Information
- 11.6.2 Johnson & Johnson Description, Business Overview and Total Revenue
- 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Johnson & Johnson Migraine Drugs Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 Endo International
- 11.7.1 Endo International Corporation Information
- 11.7.2 Endo International Description, Business Overview and Total Revenue
- 11.7.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Endo International Migraine Drugs Products Offered
- 11.7.5 Endo International Recent Development
- 11.8 GlaxoSmithKline
- 11.8.1 GlaxoSmithKline Corporation Information
- 11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 GlaxoSmithKline Migraine Drugs Products Offered
- 11.8.5 GlaxoSmithKline Recent Development
- 11.9 Impax
- 11.9.1 Impax Corporation Information
- 11.9.2 Impax Description, Business Overview and Total Revenue
- 11.9.3 Impax Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Impax Migraine Drugs Products Offered
- 11.9.5 Impax Recent Development
- 11.10 Abbott
- 11.10.1 Abbott Corporation Information
- 11.10.2 Abbott Description, Business Overview and Total Revenue
- 11.10.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Abbott Migraine Drugs Products Offered
- 11.10.5 Abbott Recent Development
- 11.1 Allergan
- 11.1.1 Allergan Corporation Information
- 11.1.2 Allergan Description, Business Overview and Total Revenue
- 11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Allergan Migraine Drugs Products Offered
- 11.1.5 Allergan Recent Development
- 11.12 Eli Lilly
- 11.12.1 Eli Lilly Corporation Information
- 11.12.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.12.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Eli Lilly Products Offered
- 11.12.5 Eli Lilly Recent Development
- 11.13 Ethypharm
- 11.13.1 Ethypharm Corporation Information
- 11.13.2 Ethypharm Description, Business Overview and Total Revenue
- 11.13.3 Ethypharm Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Ethypharm Products Offered
- 11.13.5 Ethypharm Recent Development
- 11.14 Kowa Pharmaceuticals America
- 11.14.1 Kowa Pharmaceuticals America Corporation Information
- 11.14.2 Kowa Pharmaceuticals America Description, Business Overview and Total Revenue
- 11.14.3 Kowa Pharmaceuticals America Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Kowa Pharmaceuticals America Products Offered
- 11.14.5 Kowa Pharmaceuticals America Recent Development
- 11.15 Winston Pharmaceuticals
- 11.15.1 Winston Pharmaceuticals Corporation Information
- 11.15.2 Winston Pharmaceuticals Description, Business Overview and Total Revenue
- 11.15.3 Winston Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Winston Pharmaceuticals Products Offered
- 11.15.5 Winston Pharmaceuticals Recent Development
- 11.16 AstraZeneca
- 11.16.1 AstraZeneca Corporation Information
- 11.16.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.16.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 AstraZeneca Products Offered
- 11.16.5 AstraZeneca Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Migraine Drugs Market Estimates and Projections by Region
- 12.1.1 Global Migraine Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Migraine Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Migraine Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Migraine Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Migraine Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Migraine Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Migraine Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Migraine Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Migraine Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Migraine Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Migraine Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Migraine Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Migraine Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Migraine Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Migraine Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Migraine Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Migraine Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Migraine Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Migraine Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Migraine Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Migraine Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Migraine Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Migraine Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Migraine Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Migraine Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Migraine Drugs is a syndicated market report, published as COVID-19 Impact on Global Migraine Drugs, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Migraine Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
